- Scrip Originals
Already a Biomedtracker subscriber? You have access to the full company record through your subscription
Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Nephraegis Therapeutics
The strategy for both funds is to back companies with a preclinical drug candidate that can be advanced through clinical proof-of-concept with a mid-sized series A round.